Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Mu

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cancer Science|September 1, 2010
Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer modelYuan Wen, Chun-Ting Wang, Tian-Tai Ma, et al.
European Journal of Medicinal Chemistry|May 21, 2022
Discovery of a potent, selective and cell active inhibitor of m<sup>6</sup>A demethylase ALKBH5Zhen Fang, Bo Mu, Yang Liu, et al.
Frontiers in Genetics|October 8, 2025
Next-generation sequencing of mitochondrial DNA reveals pathogenic variants and protective haplogroup D4 in esophageal cancerXiucheng Jiang, Lan Shi, Mei Zhao, et al.
Electrophoresis|July 9, 2011
Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15Yuqin Yao, Jiong Li, Zejun Lu, et al.
Cancer Science|May 29, 2010
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in miceHua-shan Shi, Dan Li, Jing Zhang, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2026
Downregulation of Organ-Derived Activin A Attenuates Muscle Atrophy and Intramuscular Fat Infiltration in Cancer Cachexia MiceCui Wang, Lin Gao, Rui Xue, et al.
Journal of Medicinal Chemistry|January 26, 2022
Structural Optimization and Structure-Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6<i>H</i>-pyrimido[5,4-<i>b</i>][1,4]oxazin-7(8<i>H</i>)-one Derivatives as A New Class of Potent Inhibitors of Pan-Trk and Their Drug-Resistant MutantsShulei Pan, Liting Zhang, Xinling Luo, et al.
Oncology Research|October 22, 2013
Inhibition of lymphatic metastases by a survivin dominant-negative mutantGuang-Chao Xu, Peng Zhang, Fei Leng, et al.
Nature Communications|December 3, 2022
Non-classical ferroptosis inhibition by a small molecule targeting PHB2Wei Yang, Bo Mu, Jing You, et al.
Scientific Reports|August 4, 2025
Long term efficacy and safety of MICT of cardiopulmonary function in patients after TAVR extended follow up of ENERGY studyYu-Shan Li, Qiang Ren, Xing-Bo Mu, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cancer Science|September 1, 2010
Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer modelYuan Wen, Chun-Ting Wang, Tian-Tai Ma, et al.
European Journal of Medicinal Chemistry|May 21, 2022
Discovery of a potent, selective and cell active inhibitor of m<sup>6</sup>A demethylase ALKBH5Zhen Fang, Bo Mu, Yang Liu, et al.
Frontiers in Genetics|October 8, 2025
Next-generation sequencing of mitochondrial DNA reveals pathogenic variants and protective haplogroup D4 in esophageal cancerXiucheng Jiang, Lan Shi, Mei Zhao, et al.
Electrophoresis|July 9, 2011
Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15Yuqin Yao, Jiong Li, Zejun Lu, et al.
Cancer Science|May 29, 2010
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in miceHua-shan Shi, Dan Li, Jing Zhang, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2026
Downregulation of Organ-Derived Activin A Attenuates Muscle Atrophy and Intramuscular Fat Infiltration in Cancer Cachexia MiceCui Wang, Lin Gao, Rui Xue, et al.
Journal of Medicinal Chemistry|January 26, 2022
Structural Optimization and Structure-Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6<i>H</i>-pyrimido[5,4-<i>b</i>][1,4]oxazin-7(8<i>H</i>)-one Derivatives as A New Class of Potent Inhibitors of Pan-Trk and Their Drug-Resistant MutantsShulei Pan, Liting Zhang, Xinling Luo, et al.
Oncology Research|October 22, 2013
Inhibition of lymphatic metastases by a survivin dominant-negative mutantGuang-Chao Xu, Peng Zhang, Fei Leng, et al.
Nature Communications|December 3, 2022
Non-classical ferroptosis inhibition by a small molecule targeting PHB2Wei Yang, Bo Mu, Jing You, et al.
Scientific Reports|August 4, 2025
Long term efficacy and safety of MICT of cardiopulmonary function in patients after TAVR extended follow up of ENERGY studyYu-Shan Li, Qiang Ren, Xing-Bo Mu, et al.
Pageof 7